OpenAlex
PricingAboutJobs
Log inGet started
Work

Use of SGLT2 inhibitors in type 2 diabetes: weighing the risks and benefits

HTML PDF

Year: 2018
Type: review
Source: Diabetologia
DOI: 10.1007/s00125-018-4663-6
Authors: Beatrice C. Lupsa, Silvio E. Inzucchi
Institutions: Yale New Haven Hospital, Yale University
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: SGLT2 inhibitors, type 2 diabetes, empagliflozin, canagliflozin, glycosuria, HbA1c reduction, cardiovascular outcomes, diabetic nephropathy, adverse effects, genitourinary infections, euglycemic diabetic ketoacidosis, lower limb amputation, bone fractures, drug prescribing
SDG: Good health and well-being

Open Access status: bronze
OpenAlex ID: W2883001358
FWCI: 3.103
Cites: 39
Cited by: 226
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms